دورية أكاديمية
Phase II trial of Belagenpumatucel-L, a TGF-β2 antisense gene modified allogeneic tumor vaccine in advanced non small cell lung cancer (NSCLC) patients
| العنوان: | Phase II trial of Belagenpumatucel-L, a TGF-β2 antisense gene modified allogeneic tumor vaccine in advanced non small cell lung cancer (NSCLC) patients |
|---|---|
| المؤلفون: | Nemunaitis, JAff1, Aff2, Aff3, IDcgt200915_cor1, Nemunaitis, M, Senzer, NAff1, Aff2, Aff3, Snitz, P, Bedell, C, Kumar, P, Pappen, B, Maples, P B, Shawler, D, Fakhrai, H |
| المصدر: | Cancer Gene Therapy. 16(8):620-624 |
| قاعدة البيانات: | Springer Nature Journals |
Full Text Finder | تدمد: | 09291903 14765500 |
|---|---|
| DOI: | 10.1038/cgt.2009.15 |